Immunome Appoints Kinney Horn as Chief Business Officer [Yahoo! Finance]
Immunome, Inc. (IMNM)
Company Research
Source: Yahoo! Finance
best-in-class targeted cancer therapies, today announced the appointment of Kinney Horn as Chief Business Officer. Mr. Horn brings to Immunome extensive experience across life sciences corporate and business development, alliance management, and commercial strategy. "Immunome is excited to welcome Kinney to our executive team as we advance our broad pipeline of targeted therapies," stated Clay Siegall, PhD, President and Chief Executive Officer of Immunome. "With the recent acquisition of AL102, Immunome is now a clinical stage company, and Kinney's expertise in navigating the complex business landscape of biotechnology and his successful track record in forging strategic partnerships will be crucial as we expand our portfolio and enhance our development capabilities." "I am thrilled to join Immunome at such a transformative time," remarked Mr. Horn. "The opportunity to drive strategic business initiatives and expand Immunome's strong portfolio is incredibly compelling. I look for
Show less
Read more
Impact Snapshot
Event Time:
IMNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNM alerts
High impacting Immunome, Inc. news events
Weekly update
A roundup of the hottest topics
IMNM
News
- Immunome, Inc. (NASDAQ: IMNM) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $33.00 price target on the stock.MarketBeat
- Immunome GAAP EPS of -$2.51, revenue of $1.03M [Seeking Alpha]Seeking Alpha
- Immunome Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- Immunome Reports First Quarter 2024 Financial Results and Provides Business UpdateBusiness Wire
- Immunome to Present at 2024 Bank of America Healthcare ConferenceBusiness Wire
IMNM
Earnings
- 5/14/24 - Miss
IMNM
Sec Filings
- 5/14/24 - Form 424B5
- 5/14/24 - Form 10-Q
- 5/14/24 - Form 8-K
- IMNM's page on the SEC website